您的位置：首页 > 产品中心 > CP-100263 dihydrochloride hydrate
CP-100263 dihydrochloride hydrate
产品别名
CP-100263 dihydrochloride hydrate
(2R,3R)-N-[(2-Methoxyphenyl)methyl]-2-phenyl-3-piperidinamine dihydrochloride hydrate
(-)-CP 99994 dihydrochloride hydrate
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C19H24N2O·2HCl |
| Molecular weight | 369.33 |
| MDL number | MFCD18632542 |
| PubChem Substance ID【PubChem化学物质编号】 | 329823721 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | CP-100263 is an NK-1 neurokinin receptor antagonist. |
| Other Notes【其他说明】 | This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
| Legal Information【法律信息】 | Sold for research purposes under agreement from Pfizer Inc. Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥97% (HPLC) |
| form【形式】 | solid |
| manufacturer/tradename | Pfizer® |
| color【颜色】 | white to off-white |
| solubility【溶解性】 | H2O: ≥5 mg/mL |
| originator【创始人】 | Pfizer |
| storage temp.【储存温度】 | room temp |
| SMILES string | O.Cl.Cl.COc1ccccc1CN[C@@H]2CCCN[C@@H]2c3ccccc3 |
| InChI | 1S/C19H24N2O.2ClH.H2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15;;;/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3;2*1H;1H2/t17-,19-;;;/m1.../s1 |
| InChI key | KBQMYQWHOPCSMG-ONBPXQNSSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07,GHS09 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H315 - H319 - H400 |
| Precautionary Statements | P273 - P305 + P351 + P338 |
| Hazard Classifications【危险分类】 | Aquatic Acute 1 - Eye Irrit. 2 - Skin Irrit. 2 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
